Research Directory

European biopharma forecasts for 2024

Read more

EU prepares for expansion of biotech

Read more

Long overdue, the EU capital markets plan is revived

Read more

Breakthroughs for European bipharma over the horizon

Read more

European Biopharma R&D in 2023

Read more

Precision medicine is theme in quiet Q3 share market

Read more

European Biopharma doesn't skimp on R&D

Read more

New system for patents takes effect in EU

Read more

Q2 stocks: Trial results, regulatory nods help European shares

Read more

European Commission highlights access, supply in pharma proposal

Read more